dc.creatorCastilla, Eduardo E.
dc.creatorMastroiacovo, Pierpaolo
dc.date2017-10-03T16:13:04Z
dc.date2017-10-03T16:13:04Z
dc.date2011
dc.date.accessioned2023-09-26T22:29:51Z
dc.date.available2023-09-26T22:29:51Z
dc.identifierCASTILLA, Eduardo E.; MASTROIACOVO, Pierpaolo. Very Rare Defects: What Can We Learn?.American Journal of Medical Genetics Part C (Seminars in Medical Genetics), .v157, p.252–261, 2011.
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/22758
dc.identifier10.1002/ajmg.c.30315
dc.identifier1552-4876
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8879988
dc.descriptionThe International Clearinghouse for Birth Defects Surveillance and Research conducted a study on very rare defects (VRDs) to test methodologies in their population surveillance and to increase the knowledge of their epidemiology. Eight VRDs: acardia (AC), amelia (AM), bladder exstrophy (BE), cloaca exstrophy (CE), conjoined twins (CT), cyclopia (CY), "true" phocomelia (PH), and sirenomelia (SI) were selected, all of whom showed prevalences in the order of 1/100,000 births, except for BE: 1/48,000 births. Materials in this investigation from 25 million pregnancy outcomes, were provided by 22 Clearinghouse-member programs. The study protocol provided a working definition, a summary of the phenotypic characteristic, and a list of ICD-9 and ICD-10 codes for each VRDs. Learned lessons include: (1) The suspected associations of decreasing risk with advancing maternal age in AM and SI, and increasing risk in BE, and increasing frequency of twins in SI, were confirmed. (2) Morphologically similar defects showed dissimilar epidemiological characteristics, namely, AM and PH, and BE and CE. (3) Heterogeneity in total prevalences for most VRDs among different surveillance programs were attributed to operational reasons, except for SI and CT in which Amerindian ethnicity seems to be associated with higher prevalence. (4) Verbatim description is essential and must be stored in electronic files. In addition to codes. (5) Dysmorphologists or clinical geneticists are an essential part of the coordinating team of the surveillance program. (6) ICD coding system is insufficient. (7) Surveillance programs should be a valuable source of information on exposures to risk factors during pregnancy.
dc.description2030-01-01
dc.formatapplication/pdf
dc.languageeng
dc.publisherWiley
dc.rightsrestricted access
dc.subjectrare anomalies
dc.subjectanomalias congênitas raras
dc.subjectdefeitos raros
dc.subjectclearinghouse
dc.subjectICBDSR
dc.subjectrare congenital anomalies
dc.subjectrare defects
dc.subjectrare anomalies
dc.titleVery rare defects: what can we learn?
dc.typeArticle


Este ítem pertenece a la siguiente institución